• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Reneo Pharmaceuticals Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

    12/27/23 2:11:57 PM ET
    $ACNT
    $ADD
    $ARBB
    $ASST
    Steel/Iron Ore
    Industrials
    Engineering & Construction
    Consumer Discretionary
    Get the next $ACNT alert in real time by email

    Shares of Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM) shares rose sharply during Wednesday’s session after Concentra sent an acquisition proposal to acquire 100% of equity of the company for $1.80 per share.

    Reneo Pharmaceuticals shares climbed 13.6% to $1.59 on Wednesday.

    Here are some other stocks moving in today's mid-day session.

    Gainers

    • First Wave BioPharma, Inc. (NASDAQ:FWBI) shares jumped 169% to $9.90 after the company announced that it entered a non-binding term sheet to sell its Niclosamide program for the treatment of inflammatory bowel diseases.
    • Cingulate Inc. (NASDAQ:CING) gained 95.2% to $4.08.
    • RiskOn International, Inc. (NASDAQ:ROI) shares climbed 91.8% to $0.27. RiskOn International expects to announce its new generative AI platform and technology partner on Jan. 3, 2024.
    • Cytokinetics, Incorporated (NASDAQ:CYTK) surged 64.2% to $75.05 after the company announced topline results from SEQUOIA-HCM, the Phase 3 clinical trial of aficamten in patients with symptomatic obstructive hypertrophic cardiomyopathy.
    • AEye, Inc. (NASDAQ:LIDR) rose 61.2% to $3.58.
    • Vince Holding Corp. (NYSE:VNCE) jumped 42% to $3.2399.
    • Bit Brother Limited(NASDAQ:BETS) gained 38.2% to $0.0152 after jumping 111% on Tuesday.
    • Nxu, Inc. (NASDAQ:NXU) rose 34% to $4.18.
    • Virax Biolabs Group Limited (NASDAQ:VRAX) gained 32% to $1.7551.
    • Jet.AI Inc. (NASDAQ:JTAI) shares gained 28% to $2.05 after falling 39% on Tuesday.
    • Elicio Therapeutics, Inc. (NASDAQ:ELTX) jumped 25% to $8.89. Elicio Therapeutics 10% owner GKCC, LLC acquired a total of 1,213,000 shares an average price of $5.81.
    • Matinas BioPharma Holdings, Inc. (NASDAQ:MTNB) gained 24.7% to $0.2518 after the company announced results from a series of in vivo studies demonstrating oral delivery of two LNC-formulated small single-strand oligonucleotides.
    • Coherus BioSciences, Inc. (NASDAQ:CHRS) shares rose 23.8% to $2.70 after the company reported the FDA approval of UDENYCA ONBODY for pegfilgrastim-cbqv.
    • TeraWulf Inc. (NASDAQ:WULF) gained 21.3% to $2.6950 after gaining 3% on Tuesday.
    • Jiuzi Holdings, Inc. (NASDAQ:JZXN) rose 15.2% to $0.7322.
    • Burford Capital Limited (NYSE:BUR) gained 14.3% to $15.44.
    • Edgewise Therapeutics, Inc. (NASDAQ:EWTX) climbed 13.8% to $10.84.
    • Mobile Global Esports Inc. (NASDAQ:MGAM) shares rose 13.8% to $0.4380 after gaining 33% on Tuesday.
    • Wheels Up Experience Inc. (NYSE:UP) gained 12.8% to $4.74.
    • Organogenesis Holdings Inc. (NASDAQ:ORGO) surged 12.2% to $4.4550. BTIG maintained Organogenesis with a Buy and raised the price target from $4 to $6.
    • Ascent Industries Co. (NASDAQ:ACNT) rose 11.9% to $9.05 as the company reported the sale of the business of Specialty Pipe & Tube for around $55 million in an all-cash deal.
    • Mynd.ai, Inc. (NYSE:MYND) gained 10.4% to $5.20.
    • Coinbase Global, Inc. (NASDAQ:COIN) surged 7.4% to $184.89.
    • Li Auto Inc. (NASDAQ:LI) gained 5.1% to $36.20.

    Losers

    • Hallmark Financial Services, Inc. (NASDAQ:HALL) shares fell 31.4% to $1.0764. Hallmark Financial Services gave notice to Nasdaq of intention to voluntarily delist its shares of common stock from Nasdaq Global Market.
    • Baosheng Media Group Holdings Limited (NASDAQ:BAOS) fell 29.5% to $4.1050.
    • Nukkleus Inc. (NASDAQ:NUKK) shares fell 28.8% to $2.60 after jumping around 11% on Tuesday.
    • Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) fell 20.4% to $7.07 after the FDA placed a clinical hold on the IOV-LUN-202 trial in response to a recently reported Grade 5 adverse event potentially related to the non-myeloablative lymphodepletion pre-conditioning regimen.
    • Mobix Labs, Inc. (NASDAQ:MOBX) shares fell 17.1% to $5.80 after surging over 34% on Tuesday.
    • Color Star Technology Co., Ltd. (NASDAQ:ADD) dipped 15.4% to $0.33.
    • Bluejay Diagnostics, Inc. (NASDAQ:BJDX) fell 15.4% to $2.20. Bluejay Diagnostics announced initiation of multicenter clinical study evaluating symphony IL-6 in sepsis patients.
    • Golden Heaven Group Holdings Ltd. (NASDAQ:GDHG) declined 15% to $0.7880.
    • ARB IOT Group Limited (NASDAQ:ARBB) fell 14.4% to $2.2155 after surging 175% on Tuesday.
    • Asset Entities Inc. (NASDAQ:ASST) declined 13.7% to $0.6120.
    • Volcon, Inc. (NASDAQ:VLCN) fell 12.7% to $0.1224. On Dec 19, Volcon got deficiency letter from Nasdaq that the company did not meet minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2).
    • Smart for Life, Inc. (NASDAQ:SMFL) shares fell 10.8% to $1.63 after declining 7% on Tuesday.
    • Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) shares fell 9.1% to $0.2090. Brainstorm Cell Therapeutics shares gained 16% on Tuesday after the company announced that it was granted patents for Allogeneic Exosome Platform-Product in neurological disorder treatments.
    • Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ:IINN) shares fell 8.7% to $1.16. Inspira Technologies shares gained 5% on Tuesday after the company announced 95% accuracy results for HYLA Blood Sensor. Additionally, the company plans FDA submission for clearance in 2024.
    • InnSuites Hospitality Trust (NYSE:IHT) fell 8.6% to $1.4250.
    • Oncternal Therapeutics, Inc. (NASDAQ:ONCT) shares fell 6.8% to $0.5510. Oncternal Therapeutics updated the status of a recent study involving a treatment for relapsed or refractory aggressive B-cell lymphoma, including patients who have failed previous CD19 CAR-T treatment.
    • Canopy Growth Corporation (NASDAQ:CGC) fell 6.2% to $5.31.

     

    Now Read This: Amazon, Adobe And 2 Other Stocks Insiders Are Selling

    Get the next $ACNT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACNT
    $ADD
    $ARBB
    $ASST

    CompanyDatePrice TargetRatingAnalyst
    AEye Inc.
    $LIDR
    4/24/2026$3.50Buy
    Craig Hallum
    Li Auto Inc.
    $LI
    4/22/2026Underperform → Neutral
    BNP Paribas Exane
    Strive Inc.
    $ASST
    4/21/2026$36.00Buy
    H.C. Wainwright
    Elicio Therapeutics Inc.
    $ELTX
    4/15/2026$20.00Buy
    Ladenburg Thalmann
    Cytokinetics Incorporated
    $CYTK
    4/10/2026$95.00Overweight
    Wells Fargo
    Strive Inc.
    $ASST
    4/10/2026$26.00Buy
    TD Cowen
    Coinbase Global Inc.
    $COIN
    4/8/2026$140.00Equal Weight → Underweight
    Barclays
    Burford Capital Limited
    $BUR
    3/30/2026$4.75Outperform → Neutral
    Wedbush
    More analyst ratings

    $ACNT
    $ADD
    $ARBB
    $ASST
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for CIMERLI issued to COHERUS BIOSCIENCES INC

    Submission status for COHERUS BIOSCIENCES INC's drug CIMERLI (SUPPL-5) with active ingredient RANIBIZUMAB-EQRN has changed to 'Approval' on 05/21/2024. Application Category: BLA, Application Number: 761165, Application Classification:

    5/22/24 9:41:01 AM ET
    $CHRS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for LOQTORZI issued to COHERUS BIOSCIENCES INC

    Submission status for COHERUS BIOSCIENCES INC's drug LOQTORZI (SUPPL-1) with active ingredient TORIPALIMAB-TPZI has changed to 'Approval' on 04/22/2024. Application Category: BLA, Application Number: 761240, Application Classification:

    4/23/24 4:41:07 AM ET
    $CHRS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    February 16, 2024 - FDA Approves First Cellular Therapy to Treat Patients with Unresectable or Metastatic Melanoma

    For Immediate Release: February 16, 2024 Today, the U.S. Food and Drug Administration approved Amtagvi, the first cellular therapy indicated for the treatment of adult patients with a type of skin cancer (melanoma) that is unable to be removed with surgery (unresectable) or has spread to other parts of the body (metastatic) that previously has been treated with other therapies (a PD-1 blocking antibody, and if B

    2/16/24 3:48:47 PM ET
    $IOVA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ACNT
    $ADD
    $ARBB
    $ASST
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Rozanovich Yoav

    3 - Inspira Technologies OXY B.H.N. Ltd (0001837493) (Issuer)

    4/23/26 7:45:16 AM ET
    $IINN
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Malik Fady Ibraham

    4 - CYTOKINETICS INC (0001061983) (Issuer)

    4/21/26 4:22:13 PM ET
    $CYTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Haas Alesia J

    4 - Coinbase Global, Inc. (0001679788) (Issuer)

    4/20/26 4:29:52 PM ET
    $COIN
    Finance: Consumer Services
    Finance

    $ACNT
    $ADD
    $ARBB
    $ASST
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Craig Hallum initiated coverage on AEye with a new price target

    Craig Hallum initiated coverage of AEye with a rating of Buy and set a new price target of $3.50

    4/24/26 8:32:33 AM ET
    $LIDR
    Auto Parts:O.E.M.
    Consumer Discretionary

    Li Auto upgraded by BNP Paribas Exane

    BNP Paribas Exane upgraded Li Auto from Underperform to Neutral

    4/22/26 7:43:24 AM ET
    $LI
    Auto Manufacturing
    Industrials

    H.C. Wainwright initiated coverage on Strive with a new price target

    H.C. Wainwright initiated coverage of Strive with a rating of Buy and set a new price target of $36.00

    4/21/26 7:35:41 AM ET
    $ASST
    Computer Software: Prepackaged Software
    Technology

    $ACNT
    $ADD
    $ARBB
    $ASST
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Bucella Michael C. bought $19,950 worth of shares (1,338 units at $14.91), increasing direct ownership by 0.49% to 273,552 units (SEC Form 4)

    4 - TERAWULF INC. (0001083301) (Issuer)

    3/13/26 5:49:13 PM ET
    $WULF
    EDP Services
    Technology

    Director Leibowitz Arthur S bought $13,405 worth of shares (5,000 units at $2.68), increasing direct ownership by 2% to 291,014 units (SEC Form 4)

    4 - Organogenesis Holdings Inc. (0001661181) (Issuer)

    3/11/26 9:45:54 PM ET
    $ORGO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Driscoll Michael Joseph bought $26,688 worth of shares (10,000 units at $2.67), increasing direct ownership by 5% to 225,707 units (SEC Form 4)

    4 - Organogenesis Holdings Inc. (0001661181) (Issuer)

    3/11/26 5:45:41 PM ET
    $ORGO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACNT
    $ADD
    $ARBB
    $ASST
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Wheels Up Announces Changes to Board of Directors

    Delta CFO Erik Snell to Join the Board, Replacing Delta COO Dan JankiTimothy Armstrong to Retire from the Board at the 2026 Annual Meeting of Stockholders and Roger Farah Expected to be Nominated for ElectionATLANTA, April 24, 2026 /PRNewswire/ -- Wheels Up Experience Inc. (NYSE:UP) ("Wheels Up" or the "Company") today announced that Erik Snell, Executive Vice President and Chief Financial Officer of Delta Air Lines, Inc. ("Delta") has been appointed to the Company's Board of Directors (the "Board") as a Delta designee, replacing Dan Janki, Executive Vice President and Chief Operating Officer of Delta. Mr. Snell previously served on the Board from July 2021 to September 2023.

    4/24/26 6:55:00 AM ET
    $UP
    Transportation Services
    Consumer Discretionary

    AEye Announces New VP of Operations and Quality and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

    AEye, Inc. (NASDAQ:LIDR), a global leader in software-defined, high-performance lidar solutions, today announced the grant of an inducement equity award to its newly appointed Vice President Operations and Quality, Paul Berton. The grant was approved by the Compensation Committee of the Company's Board of Directors as a material inducement to Mr. Berton entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4). Mr. Berton received, as an inducement to accept employment, an incentive award of 125,000 restricted stock units (the "RSUs"). These RSUs will vest as follows: one-third of the total grant is expected to vest on May 15, 2027, and the remainder of t

    4/23/26 4:00:00 PM ET
    $LIDR
    Auto Parts:O.E.M.
    Consumer Discretionary

    'There's a Tweed for That': Canopy Growth Announces Tweed Brand Summer Campaign

    New window bags, improved potency, and sharper pricing arrive at retail Victoria Day long weekend Canopy Growth Corporation ("Canopy Growth", "Canopy" or the "Company") (TSX:WEED) (NASDAQ:CGC) today announced a refresh of Tweed, one of Canada's most recognizable cannabis brands, alongside a national summer campaign, "There's a Tweed for That." This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260423388138/en/The Tweed summer campaign launches over the Victoria Day long weekend, the traditional kickoff to the Canadian summer, spotlighting Tweed's updated portfolio, including three new flower strains and the popular Quickies pre-ro

    4/23/26 7:30:00 AM ET
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care

    $ACNT
    $ADD
    $ARBB
    $ASST
    SEC Filings

    View All

    SEC Form DEFA14A filed by Wheels Up Experience Inc.

    DEFA14A - Wheels Up Experience Inc. (0001819516) (Filer)

    4/24/26 7:07:27 AM ET
    $UP
    Transportation Services
    Consumer Discretionary

    SEC Form DEF 14A filed by Wheels Up Experience Inc.

    DEF 14A - Wheels Up Experience Inc. (0001819516) (Filer)

    4/24/26 7:05:29 AM ET
    $UP
    Transportation Services
    Consumer Discretionary

    Wheels Up Experience Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Wheels Up Experience Inc. (0001819516) (Filer)

    4/24/26 6:56:02 AM ET
    $UP
    Transportation Services
    Consumer Discretionary

    $ACNT
    $ADD
    $ARBB
    $ASST
    Financials

    Live finance-specific insights

    View All

    AEye to Report 2026 First Quarter Results on Wednesday, May 13 and Host Conference Call and Webcast

    AEye, Inc. (NASDAQ:LIDR), a global leader in software-defined, high-performance lidar solutions, today announced that it will release its 2026 first quarter financial results after market close on Wednesday, May 13, 2026. A conference call and webcast will be held on the same day, at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time). During the call, AEye CEO Matt Fisch and CFO Conor Tierney will review the company's financial results and provide a business update, followed by a question-and-answer session. Supplemental financial information will be available on the company's website prior to the conference call. The live webcast of the call with an accompanying slide presentation can be

    4/22/26 8:00:00 AM ET
    $LIDR
    Auto Parts:O.E.M.
    Consumer Discretionary

    Cytokinetics to Announce First Quarter Results on May 5, 2026

    SOUTH SAN FRANCISCO, Calif., April 21, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (NASDAQ:CYTK) today announced that it is scheduled to report first quarter results on May 5, 2026 at 4:00 PM Eastern Time. Following the announcement, Cytokinetics' senior management will host a conference call at 4:30 PM Eastern Time to discuss financial results and provide business updates. The conference call will be simultaneously webcast and can be accessed from the Investors & Media section of Cytokinetics' website at www.cytokinetics.com or directly at the following link: Cytokinetics Q1 2026 Earnings Conference Call. An archived replay of the webcast will be available via Cytokinetics' websi

    4/21/26 4:00:00 PM ET
    $CYTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Strive Announces Increase to SATA Perpetual Preferred Stock Dividend Rate to 13.00% and Bitcoin Buy

    DALLAS, April 15, 2026 (GLOBE NEWSWIRE) -- Strive, Inc. (NASDAQ:ASST, SATA)) ("Strive" or the "Company") today announced a SATA dividend rate increase of 25 bps from 12.75% to 13.00% on its Variable Rate Series A Perpetual Preferred Stock (the "SATA Stock"), effective for monthly periods commencing on or after April 15, 2026.   The Company has declared a dividend of $1.0833 per share of SATA Stock, payable on May 15, 2026, to stockholders of record at the close of business on May 1, 2026. Strive expects the dividend to qualify as a non-taxable return of capital to the extent of a stockholder's tax basis in SATA Stock for U.S federal income tax purposes. Strive also announced the purchase

    4/15/26 8:00:00 AM ET
    $ASST
    Computer Software: Prepackaged Software
    Technology

    $ACNT
    $ADD
    $ARBB
    $ASST
    Leadership Updates

    Live Leadership Updates

    View All

    Wheels Up Announces Changes to Board of Directors

    Delta CFO Erik Snell to Join the Board, Replacing Delta COO Dan JankiTimothy Armstrong to Retire from the Board at the 2026 Annual Meeting of Stockholders and Roger Farah Expected to be Nominated for ElectionATLANTA, April 24, 2026 /PRNewswire/ -- Wheels Up Experience Inc. (NYSE:UP) ("Wheels Up" or the "Company") today announced that Erik Snell, Executive Vice President and Chief Financial Officer of Delta Air Lines, Inc. ("Delta") has been appointed to the Company's Board of Directors (the "Board") as a Delta designee, replacing Dan Janki, Executive Vice President and Chief Operating Officer of Delta. Mr. Snell previously served on the Board from July 2021 to September 2023.

    4/24/26 6:55:00 AM ET
    $UP
    Transportation Services
    Consumer Discretionary

    'There's a Tweed for That': Canopy Growth Announces Tweed Brand Summer Campaign

    New window bags, improved potency, and sharper pricing arrive at retail Victoria Day long weekend Canopy Growth Corporation ("Canopy Growth", "Canopy" or the "Company") (TSX:WEED) (NASDAQ:CGC) today announced a refresh of Tweed, one of Canada's most recognizable cannabis brands, alongside a national summer campaign, "There's a Tweed for That." This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260423388138/en/The Tweed summer campaign launches over the Victoria Day long weekend, the traditional kickoff to the Canadian summer, spotlighting Tweed's updated portfolio, including three new flower strains and the popular Quickies pre-ro

    4/23/26 7:30:00 AM ET
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care

    Inspira Technologies Appoints Yoav Rozanovich as Chief Business Officer to Drive Immediate Revenue Growth and Quantum Expansion

    RA'ANANA, Israel, April 14, 2026 (GLOBE NEWSWIRE) -- Inspira Technologies OXY B.H.N. Ltd (NASDAQ:IINN, IINNW)) ("Inspira Technologies" or the "Company") today announced the appointment of Mr. Yoav Rozanovich as Chief Business Officer ("CBO") of Inspira Technologies, reinforcing its commercial execution capabilities following its expansion into quantum computing connectivity and the acquisition of the Additive Manufacturing of Electronics ("AME") business from Nano Dimension Ltd. (NASDAQ:NNDM) ("Nano Dimension"). Proven Commercial LeadershipMr. Rozanovich brings international experience across additive manufacturing, advanced electronics, and complex systems integration. From November 2021

    4/14/26 8:01:00 AM ET
    $IINN
    $NNDM
    $SSYS
    Medical/Dental Instruments
    Health Care
    Electrical Products
    Technology

    $ACNT
    $ADD
    $ARBB
    $ASST
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D filed by Organogenesis Holdings Inc.

    SC 13D - Organogenesis Holdings Inc. (0001661181) (Subject)

    11/19/24 4:05:57 PM ET
    $ORGO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by Organogenesis Holdings Inc.

    SC 13D/A - Organogenesis Holdings Inc. (0001661181) (Subject)

    11/14/24 8:09:56 PM ET
    $ORGO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Cingulate Inc.

    SC 13G/A - Cingulate Inc. (0001862150) (Subject)

    11/14/24 7:21:05 PM ET
    $CING
    Biotechnology: Pharmaceutical Preparations
    Health Care